Gerard Reilly, MD
Obstetrics & Gynecology · Cincinnati, OHNPI 1326041740
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $61,297 of the $73,827 with a category attached, or 83.0%. Channel Medsystems, Inc. accounts for 63.8% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2022 at $41,674 and has fallen 98.4% since, to $674 in 2025. Among obstetrics & gynecology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 111 payments — averaging $665.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Channel Medsystems, Inc.$47K
- Astellas Pharma US Inc$7K
- Meditrina$6K
- Boston Scientific$6K
- Pfizer$5K
- Gynesonics, Inc.$1K
- plus $3K from 20 others
Across 203 payments — averaging $3041.99 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer$414K
- AbbVie$69K
- Evofem Biosciences, Inc.$63K
- Sumitomo Pharma America, Inc.$55K
- Astellas Pharma Global Development$15K
- Channel Medsystems, Inc.$1K
What the payments were for
- Consulting fees$61,29783%
- Speaking & faculty fees$4,5106%
- Travel & lodging$2,9424%
- Food & beverage$5,0787%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Channel Medsystems, Inc. | 9 | $47,096 |
| Astellas Pharma US Inc | 19 | $6,566 |
| Meditrina | 5 | $5,866 |
| Boston Scientific | 8 | $5,723 |
| Pfizer | 5 | $4,803 |
| Gynesonics, Inc. | 9 | $1,072 |
| Allen Medical Systems | 1 | $800 |
| Aspira Women's Health Inc | 6 | $460 |
| AbbVie | 17 | $457 |
| Hologic Sales And Service, LLC | 7 | $327 |
| Myovant Sciences Inc. | 1 | $147 |
| Therapeuticsmd, Inc. | 5 | $93 |
| Intuitive Surgical | 1 | $93 |
| Lupin Inc. | 4 | $66 |
| Sage Therapeutics, LLC | 2 | $37 |
| Hologic Inc | 1 | $33 |
| Merck | 2 | $25 |
| Millicent US Inc | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| Exeltis, USA Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Medtronic | 1 | $18 |
| Bayer | 1 | $18 |
| Mayne Pharma Commercial LLC | 1 | $16 |
| Caldera Medical, Inc | 1 | $14 |
| Organon | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veozah$6,311
- aveta$5,600
- GENERAL UTERINE TISSUE REMOVAL$5,100
- MYFEMBREE$4,885
- SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM$1,021
- Yellofins Stirrups with Lift Assist$800
- GENERAL - THERAPIES$447
- OVA1$365
- Orilissa$229
- ACESSA PROVU SYSTEM$148
How this compares
$73,827 in reported general payments places this provider in the 95th percentile of 1,376 obstetrics & gynecology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 11 | $6,153 |
| Estradiol | 62 | $1,657 |
| Clobetasol Propionate | 16 | $400 |
| Medroxyprogesterone Acetate | 17 | $322 |
| Alendronate Sodium | 27 | $303 |
| Oxybutynin Chloride ErOxybutynin Chloride | 23 | $219 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 14 | $176 |
| Nystatin | 11 | $101 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $4,803 | $6,15311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,376 obstetrics & gynecology providers in Ohio.
Other obstetrics & gynecology in Cincinnati
- David SchwartzCincinnati$169K
- Michael KarramCincinnati$47K
- Sunbal JavaidCincinnati$32K
- James SosnowskiCincinnati$31K
- Gretchen FermannCincinnati$31K
- Rocco RossiCincinnati$18K
- Meredith PensakCincinnati$14K
- David DhanrajCincinnati$12K
- David SheynCincinnati$10K
- Samir AhujaMentor$430K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.